Glucose Measurement Patents (Class 600/365)
  • Publication number: 20140371561
    Abstract: The specification describes a cartridge for insertion into a meter, the interior of the meter comprising a boss having a main body and a protrusion extending from the main body. The cartridge comprises an orientation member provided at one end of the cartridge, the orientation member comprising a recess having a cross-sectional shape corresponding to that of the boss and configured to receive the boss therein, the orientation member further comprising a ramp surrounding at least part of the portion of the recess corresponding to the main body, the portion of the recess which corresponds to the protrusion adjoining the lower end of the ramp via a step.
    Type: Application
    Filed: January 9, 2013
    Publication date: December 18, 2014
    Inventors: Frank Richter, Ross MacArthur, Elizabeth Verity Wolseley-Hext, Joseph David Cowan, Lee Thomas Smith, David John Mills
  • Publication number: 20140371553
    Abstract: The systems, methods, and devices described herein generally involve monitoring and/or quantification of various analyte levels in a biological fluid using one or more implantable sensors. In various aspects, systems, methods, and devices described herein can provide for the in situ calibration and/or cleaning of such sensors when implanted in the patient. The systems and devices disclosed herein can, for example, continuously or serially measure analytes within a biological fluid in vivo (e.g., without extracting the biological fluid from the patient) and periodically calibrate and/or clean the sensor without using finger sticks or additional, invasive calibration techniques. By way of non-limiting example, systems and devices disclosed herein can enable continuous monitoring of analyte concentrations (e.g., glucose) in subcutaneous interstitial fluid for several hours to a few days.
    Type: Application
    Filed: December 17, 2012
    Publication date: December 18, 2014
    Inventor: James WINKELMAN
  • Patent number: 8911367
    Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
    Type: Grant
    Filed: March 26, 2007
    Date of Patent: December 16, 2014
    Assignee: Dexcom, Inc.
    Inventors: Mark Brister, Mark Shults, Sean Saint, James R. Petisce, David K. Wong, Kum Ming Woo
  • Patent number: 8911369
    Abstract: Disclosed herein are systems and methods for a continuous analyte sensor, such as a continuous glucose sensor. One such system utilizes first and second working electrodes to measure additional analyte or non-analyte related signal. Such measurements may provide a background and/or sensitivity measurement(s) for use in processing sensor data and may be used to trigger events such as digital filtering of data or suspending display of data.
    Type: Grant
    Filed: December 15, 2008
    Date of Patent: December 16, 2014
    Assignee: Dexcom, Inc.
    Inventors: Mark Brister, James R. Petisce, Peter Simpson
  • Publication number: 20140364711
    Abstract: The embodiments herein discuss an analyte sensing processor housed in the external, detachable case of a mobile device. The analyte sensing processor converts the reading into a signal that can be further processed by a health management system and displayed on the graphical user interface of a user's device.
    Type: Application
    Filed: March 11, 2014
    Publication date: December 11, 2014
    Inventors: Moussa Omar Ismail, Haroon Ismail, Aaqib Mohammed Habib, Fahad Masood
  • Patent number: 8909314
    Abstract: The present invention relates generally to systems and methods for increasing oxygen availability to implantable devices. The preferred embodiments provide a membrane system configured to provide protection of the device from the biological environment and/or a catalyst for enabling an enzymatic reaction, wherein the membrane system includes a polymer formed from a high oxygen soluble material. The high oxygen soluble polymer material is disposed adjacent to an oxygen-utilizing source on the implantable device so as to dynamically retain high oxygen availability to the oxygen-utilizing source during oxygen deficits. Membrane systems of the preferred embodiments are useful for implantable devices with oxygen-utilizing sources and/or that function in low oxygen environments, such as enzyme-based electrochemical sensors and cell transplantation devices.
    Type: Grant
    Filed: July 20, 2011
    Date of Patent: December 9, 2014
    Assignee: DexCom, Inc.
    Inventors: James R. Petisce, Mark A. Tapsak, Peter C. Simpson, Victoria E. Carr-Brendel, James H. Brauker
  • Publication number: 20140357972
    Abstract: A variable data usage personal medical system including a self-care device attached to a patient, and operable to generate self-care device data and to transmit the self-care device data at a fixed interval; a cellular communication device operable to receive and store the transmitted self-care device data, to register a count at an interval counter for each of the fixed intervals in which the transmitted self-care device data is received, to generate a data cellular packet from overhead plus the stored self-care device data when the interval counter equals a fixed interval index, and to transmit the data packet; and a cloud infrastructure operably connected to the cellular communication device over a cellular network, and operable to receive, process, and store the transmitted data packet. The cloud infrastructure is operable to transmit a value for the fixed interval index to the cellular communication device for storage.
    Type: Application
    Filed: May 29, 2013
    Publication date: December 4, 2014
    Applicant: MEDTRONIC MINIMED, INC.
    Inventors: Fan Meng, Gary A. Cohen, Eileen H. Dempster, George W. Patterson, Cary D. Talbot, Mark Sebastian Verghese, Maral Gharib
  • Patent number: 8903466
    Abstract: A system for non-invasive measurement of a substance, such as glucose, includes a detector configured to sense radiation and an optical subsystem configured to focus the radiation on a sensitive area of the detector. The system includes one or more temperature sensors attached to one or more of a plurality of elements of the optical subsystem and to the detector and two or more temperature sensors configured to measure two or more respective ambient temperatures. The one or more temperature sensors are configured to measure the temperature of the one or more elements of the optical subsystem and the temperature of the detector. A method of measuring a concentration includes detecting an infrared radiation value, measuring the temperature of the detector, one or more components of the optical system, and two or more ambient temperatures, and correlating the temperatures with calibration parameters to correct the detected infrared radiation value.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: December 2, 2014
    Assignee: GlucoVista Inc.
    Inventor: Yonatan Gerlitz
  • Publication number: 20140350371
    Abstract: An apparatus comprising a pump, a user interface, and a controller communicatively coupled to the pump and the user interface. The controller is adapted to receive information relating to a blood glucose level of a user, determine whether the blood glucose level differs from a target blood glucose level by a threshold value, and selectively provide or delay provision of an alert notifying the user to check the user's blood glucose level. Other devices, systems, and methods are disclosed.
    Type: Application
    Filed: August 8, 2014
    Publication date: November 27, 2014
    Inventors: Michael L. Blomquist, Kevin Kopp, Thomas Alan Savard
  • Publication number: 20140350370
    Abstract: The disclosure provides a ligand that competes with glucose for binding the protein Concanavalin A (ConA) and competitive binding assays incorporating the ligand. The competing ligand binds to the primary and part or all of the extended binding sites of Concanavalin A. These and other aspects of the disclosure are useful for glucose monitoring (e.g., continuous glucose monitoring (CGM)).
    Type: Application
    Filed: April 8, 2014
    Publication date: November 27, 2014
    Applicant: THE TEXAS A&M UNIVERSITY SYSTEM
    Inventors: Brian M. Cummins, Gerard L. Coté
  • Publication number: 20140350369
    Abstract: A system and method provides a glucose report for determining glycemic risk based on an ambulatory glucose profile of glucose data over a time period, a glucose control assessment based on median and variability of glucose, and indicators of high glucose variability. Time of day periods are shown at which glucose levels can be seen. A median glucose goal and a low glucose line provide coupled with glucose variability provide a view into effects that raising or lowering the median goal would have. Likelihood of low glucose, median glucose compared to goal, and variability of glucose below median provide probabilities based on glucose data. Patterns can be seen and provide guidance for treatment.
    Type: Application
    Filed: March 15, 2014
    Publication date: November 27, 2014
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Erwin S. Budiman, Gary A. Hayter, Kenneth J. Doniger, Timothy C. Dunn, Nathan C. Crouther, Glenn H. Berman, Howard A. Wolpert
  • Publication number: 20140350360
    Abstract: Apparatus and methods are described, including a method for detecting an onset of a hypoglycemia episode in a subject. One or more critical parameters for hypoglycemia are monitored without contacting the subject. A variation of at least one of the critical parameters is detected, and an alarm is activated when at least one of the critical parameters deviates from an accepted value. Other applications are also described.
    Type: Application
    Filed: August 7, 2014
    Publication date: November 27, 2014
    Inventors: Avner Halperin, Arkadi Averboukh
  • Publication number: 20140343387
    Abstract: The present invention described a system for an energized ophthalmic device with a media insert that includes microfluidic elements upon or within the media insert. In some embodiments, the microfluidic elements may be useful for the purpose of analyzing an analyte such as glucose in a fluid sample. In addition, some embodiments can function with a medicament administering device to treat an abnormal condition identified during the analyte analysis in the fluid sample.
    Type: Application
    Filed: May 17, 2013
    Publication date: November 20, 2014
    Applicant: Johnson & Johnson Vision Care, Inc.
    Inventors: Randall B. PUGH, Frederick A. FLITSCH, Karson S. PUTT
  • Patent number: 8886272
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: February 22, 2006
    Date of Patent: November 11, 2014
    Assignee: DexCom, Inc.
    Inventors: Mark Brister, Steve Masterson, Sean Saint, Peter Simpson, Matthew D. Wightlin, James R. Petisce, Jack Pryor, Vance Swanson, John Nolting
  • Patent number: 8886275
    Abstract: An eye-mountable device includes an electrochemical sensor embedded in a polymeric material configured for mounting to a surface of an eye. The electrochemical sensor includes a working electrode and a reference electrode that reacts with an analyte to generate a sensor measurement related to a concentration of the analyte in a fluid to which the eye-mountable device is exposed. An example assembly process includes: forming a sacrificial layer on a working substrate; forming a first layer of a bio-compatible material on the sacrificial layer; providing an electronics module on the first layer of the bio-compatible material, forming a second layer of the bio-compatible material to cover the electronics module; and annealing the first and second layers of the bio-compatible material together to form an encapsulated structure having the electronics module fully encapsulated by the bio-compatible material.
    Type: Grant
    Filed: September 19, 2013
    Date of Patent: November 11, 2014
    Assignee: Google Inc.
    Inventors: James Etzkorn, Babak Amirparviz
  • Patent number: 8886273
    Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: November 11, 2014
    Assignee: Dexcom, Inc.
    Inventors: Ying Li, Apurv Ullas Kamath, Richard C. Yang
  • Patent number: 8887148
    Abstract: Embodiments described herein include methods and/or systems for updating a medical device. Embodiments include medical devices which are configured for updates in response to various events including connection of a peripheral device to the medical device, a user initiated event, or based on received recommendations.
    Type: Grant
    Filed: May 12, 2014
    Date of Patent: November 11, 2014
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Namvar Kiaie, Jean-Pierre Cole
  • Patent number: 8886274
    Abstract: The estimation of the variation of the glucose level in the blood of a person by the variation of the volume of the interstitial fluid compartments in muscular tissue due to a shift of fluid between the extracellular and intracellular compartments caused by variations of the osmotic pressure of the extracellular fluids which is in turn correlated with the glucose level. The variation of the volume of the interstitial fluid compartments is detected by a non-invasive conductometry measurement using electrodes placed in contact with the skin of the person overlying a portion of soft tissue including muscular fibers. To eliminate the adverse effect of the conductivity of the capillary vessels, the conductivity of the tissue is measured independently in two directions, namely parallel and transverse to the muscular fibers.
    Type: Grant
    Filed: August 26, 2009
    Date of Patent: November 11, 2014
    Assignee: Gerinova AG
    Inventors: Monica Gericke, Boris A. Paramonov, Ivan Ivanovich Turkovskiy
  • Patent number: 8882665
    Abstract: Subject matter disclosed herein relates to monitoring and/or controlling levels of an analyte in bodily fluid. In particular, estimation of a concentration of the analyte in a first physiological compartment based upon observations of a concentration of the analyte in a second physiological compartment may account for a latency in transporting the analyte between the first and second physiological compartments.
    Type: Grant
    Filed: October 26, 2011
    Date of Patent: November 11, 2014
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Ning Yang, Rebecca K. Gottlieb, Keith Nogueira, Xiaolong Li, Bradley Liang
  • Patent number: 8880139
    Abstract: An eye-mountable device includes an electrochemical sensor embedded in a polymeric material configured for mounting to a surface of an eye. The electrochemical sensor includes a working electrode, a reference electrode, and a reagent that selectively reacts with an analyte to generate a sensor measurement related to a concentration of the analyte in a fluid to which the eye-mountable device is exposed. The working electrode can have a first side edge and a second side edge. The reference electrode can be situated such that at least a portion of the first and second side edges of the working electrode are adjacent respective sections of the reference electrode.
    Type: Grant
    Filed: September 23, 2013
    Date of Patent: November 4, 2014
    Assignee: Google Inc.
    Inventors: James Etzkorn, Zenghe Liu
  • Patent number: 8880137
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Grant
    Filed: April 18, 2003
    Date of Patent: November 4, 2014
    Assignee: Abbott Diabetes Care Inc.
    Inventors: James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke, Keith A. Friedman, Fredric C. Colman
  • Patent number: 8880371
    Abstract: A method for adjusting a sensor, continuous sensor or automatic measuring system in an interstitium including the steps of adjusting the steepness of a measuring curve and a standard offset (standard axis intercept) prior to the use of the sensor, continuous sensor or measuring system, and adapting the offset by a point calibration by using a reference measure or value during the use. The present invention encompasses sensors, continuous sensors or automatic measuring systems calibrated or adjusted in accordance with the method, and in some embodiments, the offset adjusted prior to use is rectified according to the difference between a value determined by the sensor, continuous sensor or measuring system taking into account the standard steepness and the reference value.
    Type: Grant
    Filed: July 26, 2006
    Date of Patent: November 4, 2014
    Assignee: Roche Diagnostics International AG
    Inventors: Uwe Beyer, Michael Krieftewirth, Ulrich Haueter
  • Publication number: 20140323837
    Abstract: A needle system for penetrating to or passing thought an object or an organ comprising a semiconductor die, one or more needles, wherein the needles slide over the plane of the die, one or more actuators that move the needles relative to the die plane, and one or more actuator drivers controlled by a controller wherein the controller instruct the needle to penetrate into or to pass through and/or retract from the object or organ. The needle system is used for drug delivery or blood extraction or blood analysis or glucose measurements or blood measurements or nerve system stimulus treatment or hair removal or skin lesions removal.
    Type: Application
    Filed: July 9, 2014
    Publication date: October 30, 2014
    Inventor: David Hirshberg
  • Patent number: 8870769
    Abstract: An inter dialytic monitoring device is disclosed which monitors in vivo preselected parameters of blood content during an inter dialytic period to monitor patient health. The monitoring device is configured to extend through and releasably engage a catheter which has been placed within a patient to monitor a patient's blood. A sensor is provided to detect the presence of selected analytes and to identify when preselected parameters have been reached.
    Type: Grant
    Filed: May 23, 2011
    Date of Patent: October 28, 2014
    Assignee: Covidien LP
    Inventor: Manish Deshpande
  • Patent number: 8870763
    Abstract: Subject matter disclosed herein relates to monitoring and/or controlling levels of an analyte in bodily fluid. In particular, estimation of a concentration of the analyte in a first physiological compartment based upon observations of a concentration of the analyte in a second physiological compartment may account for a latency in transporting the analyte between the first and second physiological compartments.
    Type: Grant
    Filed: February 3, 2012
    Date of Patent: October 28, 2014
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Ning Yang, Rebecca K. Gottlieb, Keith Nogueira, Xiaolong Li, Bradley Liang, Brian T. Kannard
  • Patent number: 8874182
    Abstract: An eye-mountable device includes an electrochemical sensor embedded in a polymeric material configured for mounting to a surface of an eye. The electrochemical sensor includes a working electrode and a reference electrode that reacts with an analyte to generate a sensor measurement related to a concentration of the analyte in a fluid to which the eye-mountable device is exposed. An example assembly process includes: forming a sacrificial layer on a working substrate; forming a first layer of a bio-compatible material on the sacrificial layer; providing an electronics module on the first layer of the bio-compatible material, forming a second layer of the bio-compatible material to cover the electronics module; and annealing the first and second layers of the bio-compatible material together to form an encapsulated structure having the electronics module fully encapsulated by the bio-compatible material.
    Type: Grant
    Filed: January 15, 2013
    Date of Patent: October 28, 2014
    Assignee: Google Inc.
    Inventors: James Etzkorn, Babak Amirparviz
  • Patent number: 8864664
    Abstract: A medical device for carrying out at least one medical function. The medical device comprises at least one control part, which can be applied to a body surface of a user, and at least one functional element, which can be inserted into a body tissue of the user at at least one insertion site. The functional element can be connected to the control part. The functional element is designed to carry out at least one medical function. The control part has at least one base part with at least one supporting surface, which faces the body surface. The base part has at least one collection channel for collecting bodily fluid emerging from the insertion site.
    Type: Grant
    Filed: August 1, 2011
    Date of Patent: October 21, 2014
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Stephan-Michael Frey, Marc Arnold, Tobias Brugger, Jürgen Braun
  • Patent number: 8865071
    Abstract: A test tape device is disclosed herein for use with a replaceable analytical tape cassette, where the device includes a housing having a cassette compartment covered by a cassette door and a housing opening for sample application, a protective cover that can be moved between a closed position covering the housing opening and a release position allowing access to the housing opening and a door lock for retaining the cassette door in the closed position, wherein the protective cover is coupled with the door lock via an interlocking mechanism, such that the door lock can only be unlocked in the release position of the cover.
    Type: Grant
    Filed: June 5, 2013
    Date of Patent: October 21, 2014
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Hao-Chih Lin, Wen Tsung Wang
  • Publication number: 20140309511
    Abstract: The disclosure is related to a medical device, a system, a method and a storage medium for prediction of a value related to a medical condition. More particularly the invention relates to prediction of glucose in the blood or prediction of blood pressure. The disclosure enables improved control of glucose in the blood or of blood pressure, since prediction can be made with higher accuracy, even when switching between dynamic modes, corresponding to different states, such as exercising. In one embodiment a medical device (1) is provided, which comprises: a predicting unit (2) for prediction of a value related to a medical condition of a patient at a future point in time, based on at least a measured present value related to the medical condition of the patient; wherein the predicting unit (2) comprises an ensemble predictor (3), for predicting the value at a future point in time, continuously adaptable to different predictor modes based on different states of the patient.
    Type: Application
    Filed: December 6, 2012
    Publication date: October 16, 2014
    Inventor: Fredrik Stål
  • Patent number: 8862197
    Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
    Type: Grant
    Filed: February 15, 2013
    Date of Patent: October 14, 2014
    Assignee: Dexcom, Inc.
    Inventors: Apurv Ullas Kamath, Peter C. Simpson, Mark Brister
  • Patent number: 8858434
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: March 10, 2005
    Date of Patent: October 14, 2014
    Assignee: DexCom, Inc.
    Inventors: Apurv Ullas Kamath, James Brauker, J. Michael Dobbles
  • Patent number: 8858435
    Abstract: An apparatus for indicating a health-related condition of a subject has an input interface for receiving a sequence of samples of a first biological quantity derived by a first measurement method, the first measurement method being an invasive measurement and having a first impact on the subject, and for receiving a sequence of samples of a second biological quantity derived by a second measurement method, the second measurement method being a non-invasive measurement and having a second impact on the subject, wherein the first biological quantity gives a more accurate indication of the health-related condition of the subject than the second biological quantity, wherein the first biological quantity and the second biological quantity have a correlation to the health-related condition of the subject, and wherein the second impact is smaller than the first impact; a predictor for providing, for a certain time, for which no sample for the first biological quantity exists, an estimated value of the first biologic
    Type: Grant
    Filed: July 23, 2010
    Date of Patent: October 14, 2014
    Assignee: Diabetes Tools Sweden AB
    Inventors: Lars Gustaf Liljeryd, Ulf Frederik Magnusson
  • Publication number: 20140303467
    Abstract: A rectangular parallelepiped-shaped cartridge main body having a protective cap removably attached to a first end side thereof has a puncture needle retainer that retains a puncture needle provided at the back of a puncture opening provided on the first end side of the cartridge main body such that the puncture needle is slidable toward the puncture opening. Furthermore, a sensor unit having a depositing opening is provided on the first end side of the cartridge main body. The sensor unit has an introduction promoting hole that communicates with an introduction channel communicating with the depositing opening and that opens to the surface of the cartridge main body. The protective cap is provided with a puncture needle protector that covers the puncture needle, a sensor protector that covers the depositing opening of the sensor unit, and a sensor protector that covers the introduction promoting hole.
    Type: Application
    Filed: October 29, 2012
    Publication date: October 9, 2014
    Inventor: Hiroshi Ando
  • Publication number: 20140303466
    Abstract: Automating the processes of receiving, storing and analyzing blood glucose readings obtained from a diabetic using one or more computer-based systems may provide a number of advantages in the management of levels of glucose in the diabetic's blood. Information regarding a blood glucose reading obtained from a user may be transmitted in one or more messages to the user, to an interested party (e.g. family member), or to a third party over a network, and may serve as the basis for a computer-based motivation strategy to encourage the diabetic to comply with a blood glucose management regime. Additionally, such information may be manually or automatically posted to a social network, thereby enabling the diabetic to receive words of encouragement and support from his or her social network connections, and thereby increase his or her motivation to comply with the blood glucose management regime accordingly.
    Type: Application
    Filed: April 4, 2014
    Publication date: October 9, 2014
    Applicant: Applivate, LLC
    Inventors: John Stephen Fitzpatrick, Clifton Isamu Hayashida, Harvey Zar, James McFarland, Michael Pantalon, Marianne Sharsky Pantalon
  • Patent number: 8845536
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: April 11, 2007
    Date of Patent: September 30, 2014
    Assignee: DexCom, Inc.
    Inventors: James H. Brauker, Apurv Ullas Kamath, Paul Goode, Mark Brister
  • Patent number: 8845530
    Abstract: A device, system, and method for delivering a device such as a sensor or fluid transport structure or a fluid transport structure sensor combination into, for example, mammalian skin and receiving, analyzing, and displaying signals from the device such as a sensor are disclosed. A system in accordance with embodiments of the present invention includes a reusable sensor assembly including a transmitter, microcontroller, and housing plus a disposable sensor assembly including a housing having an opening for receiving both the distal end of a biosensor, a sensor insertion guidance structure, and a transmission apparatus for transmitting signals received from the sensor to a reusable sensor assembly for transmission to an external electronic monitoring unit.
    Type: Grant
    Filed: December 28, 2007
    Date of Patent: September 30, 2014
    Assignee: iSense Corporation
    Inventors: Robert Bruce, Richard G. Sass, W. Kenneth Ward
  • Publication number: 20140288403
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: June 5, 2014
    Publication date: September 25, 2014
    Inventors: Mark Brister, Paul V. Neale, Peter C. Simpson, James H. Brauker, James Patrick Thrower, Mark Shults, Rathbun K. Rhodes, Paul V. Goode, Arnold L. Holmquist
  • Patent number: 8840562
    Abstract: Methods and systems are provided for using time-frequency warping to analyze a physiological signal. One embodiment includes applying a warping operator to the physiological signal based on the energy density of the signal. The warped physiological signal may be analyzed to determine whether non-physiological signal components are present. Further, the same warping operator may be applied to signal quality indicators, and the warped physiological signal may be analyzed based on the warped signal quality indicators. Non-physiological signal components, or types of non-physiological noise sources, may be identified based on a comparison of the physiological signal with the signal quality indicators. Non-physiological signal components may also be identified based on a neural network of known noise functions. In some embodiments, the non-physiological signal components may be removed to increase accuracy in estimating physiological parameters.
    Type: Grant
    Filed: September 13, 2010
    Date of Patent: September 23, 2014
    Assignee: Covidien LP
    Inventors: Edward M. McKenna, Daniel Jon Peters
  • Patent number: 8840553
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Grant
    Filed: February 26, 2009
    Date of Patent: September 23, 2014
    Assignee: Abbott Diabetes Care Inc.
    Inventors: James Say, Michael F. Tomasco, Adam Heller, Yoram Gal, Behrad Aria, Ephraim Heller, Phillip John Plante, Mark S. Vreeke, Keith A. Friedman, Fredric C. Colman
  • Patent number: 8843187
    Abstract: Systems and methods for minimizing or eliminating transient non-glucose related signal noise due to non-glucose rate limiting phenomenon such as ischemia, pH changes, temperatures changes, and the like. The system monitors a data stream from a glucose sensor and detects signal artifacts that have higher amplitude than electronic or diffusion-related system noise. The system replaces some or the entire data stream continually or intermittently including signal estimation methods that particularly address transient signal artifacts. The system is also capable of detecting the severity of the signal artifacts and selectively applying one or more signal estimation algorithm factors responsive to the severity of the signal artifacts, which includes selectively applying distinct sets of parameters to a signal estimation algorithm or selectively applying distinct signal estimation algorithms.
    Type: Grant
    Filed: June 1, 2010
    Date of Patent: September 23, 2014
    Assignee: DexCom, Inc.
    Inventors: Paul V. Goode, Jr., James H. Brauker, Apurv U. Kamath, James Patrick Thrower, Victoria Carr-Brendel
  • Patent number: 8844007
    Abstract: Systems and methods for continuous measurement of an analyte in a host are provided. The system generally includes a continuous analyte sensor configured to continuously measure a concentration of analyte in a host and a sensor electronics module physically connected to the continuous analyte sensor during sensor use, wherein the sensor electronics module is further configured to directly wirelessly communicate sensor information to one or more display devices. Establishment of communication between devices can involve using a unique identifier associated with the sensor electronics module to authenticate communication. Times tracked at the sensor electronics module and the display module can be at different resolutions, and the different resolutions can be translated to facilitate communication. In addition, the frequency of establishing communication channels between the sensor electronics module and the display devices can vary depending upon whether reference calibration information is being updated.
    Type: Grant
    Filed: April 6, 2012
    Date of Patent: September 23, 2014
    Assignee: DexCom, Inc.
    Inventors: Kenneth San Vicente, Indrawati Gauba, Siddharth Waichal, Andrew Walker
  • Publication number: 20140275903
    Abstract: Described are methods and systems to allow the use of a very simple physiological meter without a user input interface (i.e., buttonless) while maintaining the ability to store time linked measurement records for retrospective or prospective analysis of the measured physiological measurements with a bistable display to allow for a display of plural prior physiological measurements without necessitating the activation (e.g., turning on or manipulation of the user input interfaces) of the physiological meter.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 18, 2014
    Applicant: LifeScan Scotland Limited
    Inventors: David ELDER, Antony Smith
  • Publication number: 20140275908
    Abstract: The present invention is directed to medical articles which exhibit a color change upon exposure to an analyte of interest and to methods of detecting analytes in bodily fluid using the same.
    Type: Application
    Filed: February 26, 2014
    Publication date: September 18, 2014
    Applicant: Boston Scientific Scimed, Inc.
    Inventors: Nathan Zamarripa, Jeff Gray
  • Publication number: 20140275905
    Abstract: Disclosed herein is a surgical mesh with a layer of dehydrated basement membrane formed thereon. Methods of making and using the mesh also are disclosed.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 18, 2014
    Inventors: Ulrike W. Klueh, Donald L. Kreutzer
  • Publication number: 20140275904
    Abstract: Disclosed herein is an analyte sensor having a sensing end with dehydrated basement membrane formed thereon. Methods of making and using the sensor also are disclosed.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 18, 2014
    Inventor: Cell and Molecular Tissue Engineering, LLC
  • Publication number: 20140275906
    Abstract: A garment for a medical device comprises a front panel; a back panel; at least one opening for a body part; at least one pocket; and at least one fastener. In some embodiments, the garment can be worn by the user of an insulin pump.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Inventor: Steven Richard Hackenburg
  • Publication number: 20140275907
    Abstract: Systems, devices, and methods are provided that enable the sensing of an analyte level within, e.g., the dermal layer of the skin of a subject. These systems, devices, and methods can utilize modalities that increase perfusion in an area local to a dermal sensor.
    Type: Application
    Filed: February 5, 2014
    Publication date: September 18, 2014
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Benjamin Jay Feldman, Hyun Cho, Austin Leach, John Charles Mazza
  • Publication number: 20140275881
    Abstract: In an embodiment, a patient monitor, such as a pulse oximeter, functions as a spot check glucometer when in communication with a blood glucose strip reader. In an embodiment, communications between the patient monitor and the strip reader may optionally be encrypted. Embodiments also include the strip reader housed in a dongle configured to mate with a sensor port of the pulse oximeter.
    Type: Application
    Filed: March 4, 2014
    Publication date: September 18, 2014
    Applicant: Cercacor Laboratories, Inc.
    Inventors: Marcelo M. Lamego, Jeroen Poeze, Cristiano Dalvi, Hung Vo, Ferdyan Lesmana, Gregory A. Olsen, Sean Merritt, Ashish Patel
  • Publication number: 20140275851
    Abstract: A variety of methods and arrangements for sharing medical data are described. In one aspect, one or more data streams are received from one or more medical imaging/sensing or other types of devices. Frames are obtained from the streams. In some embodiments, particular frames and/or parts of frames are selectively encrypted. The frames are transmitted to a remote device, where they are rendered and/or displayed at the remote device. In various embodiments, the frames of different streams are synchronized.
    Type: Application
    Filed: May 30, 2014
    Publication date: September 18, 2014
    Inventors: Ravi N. AMBLE, Harish P. HIRIYANNAIAH, Farooq Mirza Mohammad RAZA, Steven J. SALVE
  • Publication number: 20140275847
    Abstract: A method and system is presented for an implantable wireless power receiver for use with a medical stimulation or monitoring device. The receiver receives transmitted energy through one or more non-inductive antenna(s), utilizes microelectronics to perform rectification of the received signal for generation of a DC power supply to power an implantable device, and may also utilize microelectronics to provide parameter settings to the device, or stimulating or other waveforms to a tissue.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Inventors: Laura Tyler Perryman, Chad Andresen